Literature DB >> 33474580

Demographic predictors of hospitalization and mortality in US children with COVID-19.

Alvaro Moreira1, Kevin Chorath2, Karthik Rajasekaran2, Fiona Burmeister3, Mubbasheer Ahmed4, Axel Moreira4.   

Abstract

Understanding which children are at increased risk for poor outcome with COVID-19 is critical. In this study, we link pediatric population-based data from the US Center for Disease Control and Prevention to COVID-19 hospitalization and in-hospital death. In 27,045 US children with confirmed COVID-19, we demonstrate that African American [OR 2.28 (95% CI: 1.93, 2.70)] or mixed race [OR 2.95 (95% CI: 2.28, 3.82)] and an underlying medical condition [OR 3.55 (95% CI: 3.14, 4.01)] are strong predictors for hospitalization. Death occurred in 39 (0.19%) of 20,096 hospitalized children; children with a prior medical condition had an increased odd for death [OR 8.8 (95% CI: 3.7, 21.1)].
Conclusion: Hospitalization and in-hospital death are rare in children diagnosed with COVID-19. However, children at higher risk for these outcomes include those with an underlying medical condition, as well as those of African American descent. What is Known: • Demographic factors are independent prognosticators of poor outcome in children with COVID-19. What is New: • Children with an underlying medical condition and those from an African American or mixed race/ethnicity are at high risk for COVID-19 hospitalization. • History of a comorbidity supersedes age, gender, and race/ethnicity as a risk factor for in-hospital pediatric COVID-19 death.

Entities:  

Keywords:  COVID-19; COVID-NET; Children; Pediatric; SARS-CoV-2

Mesh:

Year:  2021        PMID: 33474580      PMCID: PMC7817069          DOI: 10.1007/s00431-021-03955-x

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.860


Introduction

As of January 19, 2021, more than 23M cases of COVID-19 have been confirmed in the USA [1]. A recent report from the American Academy of Pediatrics and the Children’s Hospital Association estimates nearly 2.5M total COVID-19 cases in US children [2]. Previous studies have shown that age, gender, race/ethnicity, and underlying medical conditions are independent risk factors for poor outcome in COVID-19 [3-6]. Understanding the role these factors play in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may inform clinicians, researchers, and governing agencies which children are at highest risk for severe COVID-19. Thus, our goal was to quantify the relationship between demographic factors and US pediatric COVID-19 hospitalization and death.

Methods

The Centers for Disease Control and Prevention COVID-19-associated hospitalization surveillance network (CDC COVID-NET) is a population-based system that captures laboratory-confirmed COVID-19 cases in over 250 US acute-care hospitals [7]. s -. The CDC COVID-NET is comprised of demographic variables (e.g., gender, age group, race and ethnicity, medical conditions) and date of positive SARS-CoV-2 test, as well as outcomes, including hospitalization and mortality. Evidence of COVID-19 cases were evaluated for a postive detection of SARS-CoV-2 via nasopharyngeal/throat swabs or serologic testing.The database stratifies the variables as follows: Age group: stratified to 0–9 years or 10–19 years Gender: male or female Race and ethnicity: White, Non-Hispanic (NH); Black, NH; Hispanic/Latino; Asian, NH; Multiple/other, NH, Hawaiian/Pacific Islander, NH; Alaskan/American Indian, NH Medical condition: yes or no Hospitalization: yes or no Death: yes or no Our primary outcomes were hospitalization and in-hospital mortality. The data from the CDC COVID-NET was downloaded on August 17, 2020, and captured pediatric COVID-19 rates in the USA between March 2, 2020, and July 16, 2020. Although the database included a total of 229,052 children, we only included children that had complete information (e.g., no missing data). We examined the association of age, gender, race and ethnicity, and medical condition on hospitalization, followed by in-hospital mortality. The following underlying illnesses yielded a “yes” answer on the “medical condition” field: asthma, autoimmune disease, cardiovascular disease, chronic lung disease, gastrointestinal/liver disease, hypertension, immune suppression, metabolic disease, neurologic disease, obesity, pregnancy, renal disease, or other disease. All demographic variables were included in the multivariable logistic regression model. Odds ratios (OR) with 95% confidence intervals (CI) were calculated. A p value < 5% was considered statistically significant. Analyses were performed in STATA (version 13, College Station, TX). Since the data is publicly available and reported in a de-identified fashion, ethical approval to analyze the data was not warranted by local authorities.

Results

Hospitalization

A total of 27,045 US children with COVID-19 were included in this report. The majority (n = 18,924; 70.0%) of children were between the ages of 10 and 19 years with a similar gender distribution (please refer to Table 1). Hispanic/Latino, White, non-Hispanic, and Black, non-Hispanic totaled 90.3% of the population. Thirty-nine percent (n = 10,438) of the children had an underlying medical condition.
Table 1

Demographic characteristics of hospitalized US children with COVID-19

VariableTotal (n = 27,045)Non-hospitalized (n = 25,771)Hospitalized (n = 1,274)p value
Age< 0.01
  0–9 years8,1217,639 (94.1%)482 (5.9%)
  10–19 years18,92418,132 (95.8%)792 (4.2%)
Sex0.99
  Female13,95913,299 (95.3%)660 (4.7%)
  Male13,08612,472 (95.3%)614 (4.7%)
Race/ethnicity< 0.01
  White, NH7,9747,717 (96.8%)257 (3.2%)
  Black, NH4,2243,876 (91.8%)348 (8.2%)
  Hispanic/Latino12,23611,697 (95.6%)539 (4.4%)
  Asian, NH972936 (96.3%)36 (3.7%)
  Multiple/other, NH980894 (91.2%)86 (8.8%)
  Hawaiian/Pacific Islander, NH478471 (98.5%)7 (1.5%)
  Alaskan/American Indian, NH181180 (99.4%)1 (0.6%)
Comorbidity< 0.01
  No16,60716,195 (97.5%)412 (2.5%)
  Yes10,4389,576 (91.7%)862 (8.3%)

NH non-Hispanic

Demographic characteristics of hospitalized US children with COVID-19 NH non-Hispanic Of the 27,045 children, 1,274 (4.7%) required hospitalization. Multivariate analysis demonstrated that age, race/ethnicity, and medical conditions were significant features for hospitalization. Specifically, COVID-19-positive children < 10 years of age [OR 1.5 (95% CI 1.3, 1.7)] who were Black or of mixed race/ethnicity, and with a medical condition [OR 3.6 (95% CI 3.1, 4.0)] associated with a higher odd for hospitalization (see Table 2).
Table 2

Multivariable logistic regression evaluating risk factors associated with US pediatric COVID-19 hospitalization (n = 27,045)

VariableOdds ratio95% CIp value
Age
  0–9 years1.481.31–1.67< 0.01
  10–19 years1 (reference)
Sex
  Female1.030.92–1.160.56
  Male1 (reference)
Race/ethnicity
  White, NH1 (reference)
  Black, NH2.281.93–2.70< 0.01
  Hispanic/Latino1.381.19–1.61< 0.01
  Asian, NH1.110.78–1.610.56
  Multiple/other, NH2.952.28–3.82< 0.01
  Hawaiian/Pacific Islander, NH0.250.12–0.54< 0.01
  Alaskan/American Indian, NH0.200.03–1.420.11
Comorbidity
  No1 (reference)
  Yes3.553.14–4.01< 0.01

CI confidence interval, NH non-Hispanic

Multivariable logistic regression evaluating risk factors associated with US pediatric COVID-19 hospitalization (n = 27,045) CI confidence interval, NH non-Hispanic

Mortality

Mortality data was available for 20,096 (74.3%) individuals that were hospitalized (refer to Table 3). Death occurred in 39 (0.19%) hospitalized children. Demographic differences observed between survivors and non-survivors included race and an underlying medical condition. Children who were black, non-Hispanic [OR 3.0 (95% CI 1.3, 6.7)], and those with an underlying medical condition [OR 8.8 (95% CI 3.7, 21.1)] had an increased odd for death. Please see Table 4 for more details.
Table 3

Demographic characteristics of COVID-19-positive children with in-hospital death

VariableTotal (n = 20,096)Survivors (n = 20,057)Non-survivor (n = 39)p value
Age0.69
  0–9 years6,1046,091 (99.8%)13 (0.2%)
  10–19 years13,99213,966 (99.8%)26 (0.2%)
Sex0.95
  Female10,41510,395 (99.8%)20 (0.2%)
  Male9,6819,662 (99.8%)19 (0.2%)
Race/ethnicity< 0.01
  White, NH6,2316,222 (99.9%)9 (0.1%)
  Black, NH3,1823,166 (99.5%)16 (0.5%)
  Hispanic/Latino89768,965 (99.9%)11 (0.1%)
  Asian, NH645645 (100%)0 (0%)
  Multiple/other, NH677674 (99.6%)3 (0.4%)
  Hawaiian/Pacific Islander, NH273273 (100%)0 (0%)
  Alaskan/American Indian, NH112112 (100%)0 (0%)
Comorbidity< 0.01
  No12,58112,575 (99.95%)6 (0.05%)
  Yes7,5157,482 (99.6%)33 (0.4%)

NH non-Hispanic

Table 4

Multivariable logistic regression evaluating risk factors associated with pediatric COVID-19 in-hospital death (n = 20,096)

VariableOdds ratio95% CIp value
Age
  0–9 years1.240.63–2.430.53
  10–19 years1 (reference)
Sex
  Female0.980.52–1.850.96
  Male1 (reference)
Race/ethnicity
  White, NH1 (reference)
  Black, NH2.961.30–6.730.01
  Hispanic/Latino0.880.36–2.130.78
  Asian, NH1
  Multiple/other, NH3.330.90–12.370.07
  Hawaiian/Pacific Islander, NH1
  Alaskan/American Indian, NH1
Comorbidity
  No1 (reference)
  Yes8.823.68–21.1< 0.01

CI confidence interval, NH non-Hispanic

Demographic characteristics of COVID-19-positive children with in-hospital death NH non-Hispanic Multivariable logistic regression evaluating risk factors associated with pediatric COVID-19 in-hospital death (n = 20,096) CI confidence interval, NH non-Hispanic

Discussion

In a large US cohort of confirmed COVID-19 children, we found that hospitalization occurred 4.7% of the time with an in-hospital mortality rate of 0.19%. Cases of COVID-19 were more frequently observed in children older than 10 years of age and those of Hispanic/Latino and White, non-Hispanic race/ethnicity. However, children more likely to be hospitalized or die were Black, non-Hispanic and children with an underlying health condition. Interestingly, medical condition was the strongest risk factor for a poor outcome. Our data showed that Black, non-Hispanic and Hispanic children were 2.5 times more likely than White children to be hospitalized and 5 times more likely to die after infection with SARS-CoV-2. Several reasons exist for this continued pattern of disproportionate impact of COVID-19 in minorities. First, parents are among the greatest vector of the disease to children [6]. As such, parents who work in high “viral-contact” jobs are more likely to be minorities. For example, Williams et al. [8] described that many of the industries (e.g., gyms, hair salons, restaurants) that remained open during the pandemic are driven by workers who are predominantly minority. Second, poverty is more common among minority groups. A study by Adhikari and colleagues [9] concluded that counties with higher rates of poverty and those with more diverse populations had significantly higher infection and death rates compared to counties with a substantial White population. Next, lower socioeconomic status is intricately linked to larger household sizes, crowding, and therefore more cross-infection [10]. This emphasized the needed to untangle the differences in immunologic response to SARS-CoV-2 based on race/ethnicity [11]. A past medical history of an underlying condition was the strongest risk factor for poor outcome in US children with COVID-19. An earlier report in Morbidity and Mortality Weekly Report noted that Hispanic and non-Hispanic Black children had a higher prevalence of underlying conditions when compared to White children (45.7% vs. 29.8% vs. 14.9%, respectively) [5]. Similarly, our analysis of 27,045 pediatric cases of COVID-19 found that Black, non-Hispanic children had a higher proportion of comorbidities when compared to White children (49.6% vs. 37.3%). Our findings that comorbidity and minority populations are at increased risk for COVID-19 death is reiterated in a study by Ahmed et al. [12]. Another recent meta-analysis examined the association of pediatric comorbidities with COVID-19 infection. In 42 studies, encompassing 275,661 children, Tsankov et al. summarized that children with comorbidities had a relative risk ratio of 1.79 for severe COVID-19 infection and 2.81 for COVID-19-related mortality. There are limitations to our study. First, although the data is derived from 14 states, it only represents 10% of the US population. Second, missing data was common in the database which decreased our overall sample size from 229,052 children to 27,045 pediatric cases. In particular, medical conditions had more than 50% of the data unknown or missing. Despite finding that a history of medical conditions impacts the trajectory of childhood COVID-19, the database is not granular in providing the specific conditions for each patient. To our knowledge, this is the largest pediatric evaluation investigating demographic information as risk factors of COVID-19 hospitalization and death. Implications from our study are threefold: (i) gender may not play a significant role in childhood COVID-19 severity, (ii) race and ethnicity, and underlying medical conditions, are vital risk factors for COVID-19 hospitalization or death, and (iii) younger age increases hospitalization risk, but not death. Future studies should focus on unraveling the mechanisms underpinning poor COVID-19 outcomes in Black, non-Hispanic children, as well as those with medical conditions.

What is Known:

• Demographic factors are independent prognosticators of poor outcome in children with COVID-19.

What is New:

• Children with an underlying medical condition and those from an African American or mixed race/ethnicity are at high risk for COVID-19 hospitalization.

• History of a comorbidity supersedes age, gender, and race/ethnicity as a risk factor for in-hospital pediatric COVID-19 death.

  8 in total

1.  Reopening the United States: Black and Hispanic Workers Are Essential and Expendable Again.

Authors:  J Corey Williams; Nientara Anderson; Terrell Holloway; Ezelle Samford; Jeffrey Eugene; Jessica Isom
Journal:  Am J Public Health       Date:  2020-10       Impact factor: 11.561

2.  COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study.

Authors:  Florian Götzinger; Begoña Santiago-García; Antoni Noguera-Julián; Miguel Lanaspa; Laura Lancella; Francesca I Calò Carducci; Natalia Gabrovska; Svetlana Velizarova; Petra Prunk; Veronika Osterman; Uros Krivec; Andrea Lo Vecchio; Delane Shingadia; Antoni Soriano-Arandes; Susana Melendo; Marcello Lanari; Luca Pierantoni; Noémie Wagner; Arnaud G L'Huillier; Ulrich Heininger; Nicole Ritz; Srini Bandi; Nina Krajcar; Srđan Roglić; Mar Santos; Christelle Christiaens; Marine Creuven; Danilo Buonsenso; Steven B Welch; Matthias Bogyi; Folke Brinkmann; Marc Tebruegge
Journal:  Lancet Child Adolesc Health       Date:  2020-06-25

3.  Assessment of Community-Level Disparities in Coronavirus Disease 2019 (COVID-19) Infections and Deaths in Large US Metropolitan Areas.

Authors:  Samrachana Adhikari; Nicholas P Pantaleo; Justin M Feldman; Olugbenga Ogedegbe; Lorna Thorpe; Andrea B Troxel
Journal:  JAMA Netw Open       Date:  2020-07-01

4.  Racial disparity in Covid-19 mortality rates - A plausible explanation.

Authors:  Yuval Tal; Avner Adini; Alal Eran; Irit Adini
Journal:  Clin Immunol       Date:  2020-05-28       Impact factor: 3.969

5.  Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units.

Authors:  Lara S Shekerdemian; Nabihah R Mahmood; Katie K Wolfe; Becky J Riggs; Catherine E Ross; Christine A McKiernan; Sabrina M Heidemann; Lawrence C Kleinman; Anita I Sen; Mark W Hall; Margaret A Priestley; John K McGuire; Konstantinos Boukas; Matthew P Sharron; Jeffrey P Burns
Journal:  JAMA Pediatr       Date:  2020-09-01       Impact factor: 16.193

6.  Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis.

Authors:  Shirley Sze; Daniel Pan; Clareece R Nevill; Laura J Gray; Christopher A Martin; Joshua Nazareth; Jatinder S Minhas; Pip Divall; Kamlesh Khunti; Keith R Abrams; Laura B Nellums; Manish Pareek
Journal:  EClinicalMedicine       Date:  2020-11-12

7.  COVID-19 in 7780 pediatric patients: A systematic review.

Authors:  Ansel Hoang; Kevin Chorath; Axel Moreira; Mary Evans; Finn Burmeister-Morton; Fiona Burmeister; Rija Naqvi; Matthew Petershack; Alvaro Moreira
Journal:  EClinicalMedicine       Date:  2020-06-26

8.  Multisystem inflammatory syndrome in children: A systematic review.

Authors:  Mubbasheer Ahmed; Shailesh Advani; Axel Moreira; Sarah Zoretic; John Martinez; Kevin Chorath; Sebastian Acosta; Rija Naqvi; Finn Burmeister-Morton; Fiona Burmeister; Aina Tarriela; Matthew Petershack; Mary Evans; Ansel Hoang; Karthik Rajasekaran; Sunil Ahuja; Alvaro Moreira
Journal:  EClinicalMedicine       Date:  2020-09-04
  8 in total
  22 in total

1.  Association of Healthcare Access With Intensive Care Unit Utilization and Mortality in Patients of Hispanic Ethnicity Hospitalized With COVID-19.

Authors:  Ferdinand Velasco; Donghan M Yang; Minzhe Zhang; Tanna Nelson; Thomas Sheffield; Tony Keller; Yiqing Wang; Clark Walker; Chaitanya Katterapalli; Kelli Zimmerman; Andrew Masica; Christoph U Lehmann; Yang Xie; John W Hollingsworth
Journal:  J Hosp Med       Date:  2021-11       Impact factor: 2.960

Review 2.  COVID-19 and neurologic manifestations: a synthesis from the child neurologist's corner.

Authors:  Carolina Valderas; Gastón Méndez; Alejandra Echeverría; Nelson Suarez; Katherin Julio; Francisca Sandoval
Journal:  World J Pediatr       Date:  2022-04-27       Impact factor: 9.186

3.  Impact of environmental and individual factors on COVID-19 mortality in children and adolescents in Mexico: An observational study.

Authors:  Carlos Sanchez-Piedra; Ana-Estela Gamiño-Arroyo; Copytzy Cruz-Cruz; Francisco-Javier Prado-Galbarro
Journal:  Lancet Reg Health Am       Date:  2022-01-20

4.  COVID-19 severity determinants inferred through ecological and epidemiological modeling.

Authors:  Sofija Markovic; Andjela Rodic; Igor Salom; Ognjen Milicevic; Magdalena Djordjevic; Marko Djordjevic
Journal:  One Health       Date:  2021-11-27

5.  Risk factors for poor prognosis in children and adolescents with COVID-19: A systematic review and meta-analysis.

Authors:  Qianling Shi; Zijun Wang; Jiao Liu; Xingmei Wang; Qi Zhou; Qinyuan Li; Yang Yu; Zhengxiu Luo; Enmei Liu; Yaolong Chen
Journal:  EClinicalMedicine       Date:  2021-10-19

6.  Early report from the Pediatric Heart Transplant Society on COVID-19 infections in pediatric heart transplant candidates and recipients.

Authors:  Jennifer Conway; Scott R Auerbach; Marc E Richmond; Brandon Sharp; Elfriede Pahl; Brian Feingold; Estela Azeka; William J Dryer; Ryan S Cantor; James K Kirklin
Journal:  J Heart Lung Transplant       Date:  2021-11-19       Impact factor: 10.247

7.  A multicenter retrospective study of clinical features, laboratory characteristics, and outcomes of 166 hospitalized children with coronavirus disease 2019 (COVID-19): A preliminary report from Iranian Network for Research in Viral Diseases (INRVD).

Authors:  Iraj Sedighi; Alireza Fahimzad; Neda Pak; Mitra Khalili; Mohammad R Shokrollahi; Hosein Heydari; Zahra Movahedi; Anahita S Dashti; Fatemeh Cheraghali; Ahmad Shamsizadeh; Mohammadreza Mirkarimi; Mohsen Alisamir; Houman Hashemian; Jafar Soltani; Ali Hosseininasab; Abdolkarim Hamedi; Mohammad S Rezai; Shirin Sayyahfar; Manijeh Kahbazi; Aliakbar Abedini; Afsaneh Akhondzadeh; Hamid R Sherkatolabbasieh; Ali Akbar Razlansari; Mina Alibeik; Soheil Omid Malayeri; Zohreh Shalchi; Ali Shahabinezhad; Parinaz K Asl; Fatemeh N Monfared; Shiva Maleki; Rezvan Kakavand; Mohammad Farahmand; Babak Shahbaz; Ahmad Tavakoli; Sara A Rezayat; Mohammad R Karimi; Yousef Erfani; Ali Jafarpour; Saber Soltani; Milad Zandi; Azam Ghaziasadi; Razieh Dowran; Shohreh Azimi; Shima S Marvi; Mohammad F Abazari; Mehdi Norouzi; Iman R Azhar; Seyed M Jazayeri
Journal:  Pediatr Pulmonol       Date:  2021-11-30

8.  Pediatrics Infected with COVID-19: A Case Series Study on Pediatrics Hospitalized in a Referral Pediatric Hospital.

Authors:  Houman Hashemian; Saeid Sadat Mansouri; Hamid Reza Badeli; Ebrahim Esmaili; Majid Asgharzadeh; Tamkin Shahraki; Neda Aligoli Ghasemabadi; Reza Falahatkar; Parham Mashouf; Alireza Jafari
Journal:  Int J Pediatr       Date:  2021-12-14

9.  Racial disparities in COVID-19 pandemic cases, hospitalisations, and deaths: A systematic review and meta-analysis.

Authors:  William Mude; Victor M Oguoma; Tafadzwa Nyanhanda; Lillian Mwanri; Carolyne Njue
Journal:  J Glob Health       Date:  2021-06-26       Impact factor: 4.413

Review 10.  Death from COVID-19 in a Hispanic postpartum woman and review of the literature.

Authors:  Janardhan Mydam; Laila Younes; Mohammed Siddiqui; Thana Tarsha
Journal:  BMJ Case Rep       Date:  2021-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.